Search results
Author(s):
Clyde W Yancy
Added:
3 years ago
The US population is characterized by significant racial/ethnic demographic transitions with an emerging number of special populations at risk for cardiovascular disease. Amongst the special populations with heart disease, it is heart failure in African-Americans that has become the prototypical model.
Heart FailureÔÇöAn Enigmatic Disease in African-Americans
Chronic heart failure is no longer…
View more
Author(s):
Shawna D Nesbitt
Added:
3 years ago
Epidemiology
Hypertension is both more common and more destructive in African-Americans than in other ethnic groups. According to the 2005–2006 National Health and Nutrition Examination Survey (NHANES) data, the current prevalence of hypertension in African-Americans is 39.1%, which is well above non-Hispanic whites at 28.5%. While awareness and treatment rates are similar between African…
View more
Author(s):
Keith C Ferdinand
,
Verna L Welch
Added:
3 years ago
Hypertension is a major contributor to the global disease burden and is one of the leading preventable causes of premature death worldwide.1 In the US, a disproportionate burden of hypertension and its associated complications—including coronary heart disease, heart failure, stroke, and end-stage renal disease and cardiovascular disease mortality—affect African-Americans (also referred to as US…
View more
Author(s):
Keith C Ferdinand
Added:
3 years ago
Heart failure is a major health concern in the US and is particularly problematic in the African-American community where the disease has an earlier onset and exhibits increased mortality, even with hospitalisation. Early onset is manifested primarily in middle-aged patients, where the rates of heart failure are higher than that with a higher mortality than in whites. Between the ages of 45 and…
View more
Author(s):
Gavin L Noble
,
Gary V Heller
Added:
3 years ago
Coronary artery disease (CAD) is the leading cause of death in the US in both men and women, and in all ethnic groups that have been evaluated. The American College of Cardiology estimated the 1998 annual costs (direct and indirect) of CAD in the US to be US$368.4 billion, compared with cumulative cancer costs of US$189 billion. The national focus on cardiovascular research, diagnosis and…
View more
Author(s):
Ana Mola
,
Carmen Perez-Terzic
,
Randal Thomas
,
et al
Added:
3 years ago
The changing population landscape in the US has impacted the many levels of the US healthcare system. It is estimated that, by 2050, minority populations together will comprise approximately 50% of the total population.1 This demographic shift has prompted policy makers, scientists, researchers, educators, and healthcare providers to draft a series of national health initiatives to define,…
View more
Author(s):
Hou Tee Lu
,
Rusli Bin Nordin
,
Aizai Azan Bin Abdul Rahim
Added:
3 years ago
Heart failure (HF) is a global public health problem, affecting an estimated 26 million people worldwide and resulting in more than 1 million hospitalizations annually in the US and Europe.1 This HF pandemic is also evident in Asia and other parts of the world.2–4 Although the outcomes for HF patients have improved with the discovery of multiple evidence-based drug and device therapies,…
View more
Author(s):
Kellee P Patterson
,
Keith C Ferdinand
Added:
3 years ago
“From putting knowledge before wisdom, science before art, and Cleverness before common sense; From treating patients as cases; And from making the cure of the disease more grievous than the Endurance of the same, Good Lord, deliver us.” – Sir Robert Hutchison1
“Data are not facts; facts are not information; information is not truth; truth is not wisdom. The wise application of empirical facts…
View more
Author(s):
Gavin L Noble
,
Gary V Heller
Added:
3 years ago
Introduction
Coronary artery disease (CAD) is the leading cause of death in the US in both men and women, and in all ethnic groups that have been evaluated.1 The American College of Cardiology estimated the 1998 annual costs (direct and indirect) of CAD in the US to be US$368.4 billion, compared with cumulative cancer costs of US$189 billion.2 The scope of this problem is expanding as the…
View more
Author(s):
Keith C Ferdinand
Added:
3 years ago
Hypertension remains a prevalent, major risk factor for cardiovascular disease (CVD), affecting over one-third of adults in the uS—nearly 74 million people.1 In the uS, elevated blood pressure (BP) contributes to 69% of first myocardial infarctions (MIs), 74% of cases of congestive heart failure (CHF), and 77% of first strokes.1 The total direct and indirect cost of CVD and stroke in the US for…
View more